Stuart Barnscher is a seasoned professional in the field of ADC (Antibody-Drug Conjugate) therapeutic development, currently serving as Senior Director of Preclinical Programs at Zymeworks Inc. since April 2016. Barnscher has advanced through various roles within the company, including Director, Associate Director in Oncology, Senior Scientist, and Scientist, with a focus on ADC Conjugation Chemistry. Prior experience includes a position as Scientist at Kairos Therapeutics and an Associate Scientist role at The Centre for Drug Research & Development (CDRD). Barnscher began a career in the pharmaceutical industry as a Research Associate at Astellas Pharma, working as a synthetic ADC chemist. Barnscher holds a Bachelor of Science degree in Biochemistry and Chemistry from The University of British Columbia, earned between 2006 and 2011.
This person is not in the org chart
This person is not in any teams
This person is not in any offices